124
Views
4
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Treatment of Open-Angle Glaucoma with iStent Implantation Combined with Phacoemulsification in Polish Caucasian Population

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 473-480 | Published online: 10 Feb 2021

References

  • Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE. Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008;126(8):1030–1036. doi:10.1001/archopht.126.8.1030
  • Actis AG, Versino E, Brogliatti B, Rolle T. Risk factors for primary open angle glaucoma (POAG) progression: a study ruled in Torino. Open Ophthalmol J. 2016;10:129–139. doi:10.2174/1874364101610010129
  • Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH, Clark AF. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 2006;47(1):226–234. doi:10.1167/iovs.05-1060
  • Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789–803.e782. doi:10.1016/j.ajo.2011.10.026
  • Soltau JB, Rothman RF, Budenz DL, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118(3):338–342. doi:10.1001/archopht.118.3.338
  • SooHoo JR, Seibold LK, Radcliffe NM, Kahook MY. Minimally invasive glaucoma surgery: current implants and future innovations. Can J Ophthalmol. 2014;49(6):528–533. doi:10.1016/j.jcjo.2014.09.002
  • Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23(2):96–104. doi:10.1097/ICU.0b013e32834ff1e7
  • Caprioli J, Kim JH, Friedman DS, et al. Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the food and drug administration, Washington, DC, February 26, 2014. Ophthalmology. 2015;122(9):1795–1801. doi:10.1016/j.ophtha.2015.02.029
  • Craven ER, Katz LJ, Wells JM, Giamporcaro JE. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38(8):1339–1345. doi:10.1016/j.jcrs.2012.03.025
  • Arriola-Villalobos P, Martínez-de-la-Casa JM, Díaz-Valle D, Fernández-Pérez C, García-Sánchez J, García-Feijoó J. Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study. Br J Ophthalmol. 2012;96(5):645–649. doi:10.1136/bjophthalmol-2011-300218
  • Ferguson TJ, Berdahl JP, Schweitzer JA, Sudhagoni RG. Clinical evaluation of a trabecular microbypass stent with phacoemulsification in patients with open-angle glaucoma and cataract. Clin Ophthalmol. 2016;10:1767–1773. doi:10.2147/OPTH.S114306
  • Fea AM, Consolandi G, Zola M, et al. Micro-bypass implantation for primary open-angle glaucoma combined with phacoemulsification: 4-year follow-up. J Ophthalmol. 2015;2015:795357.
  • Konopinska J, Kozera M, Krasnicki P, Mariak Z, Rekas M. The effectiveness of first-generation iStent microbypass implantation depends on initial intraocular pressure: 24-month follow-up-prospective clinical trial. J Ophthalmol. 2020;2020:8164703.
  • Ferguson TJ, Swan R, Ibach M, Schweitzer J, Sudhagoni R, Berdahl JP. Trabecular microbypass stent implantation with cataract extraction in pseudoexfoliation glaucoma. J Cataract Refract Surg. 2017;43(5):622–626. doi:10.1016/j.jcrs.2017.02.029
  • Fea AM, Belda JI, Rękas M, et al. Prospective unmasked randomized evaluation of the iStent inject (®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol. 2014;8:875–882. doi:10.2147/OPTH.S59932
  • Le JT, Bicket AK, Wang L, Li T. Ab interno trabecular bypass surgery with iStent for open-angle glaucoma. Cochrane Database Syst Rev. 2019;3(3):Cd012743. doi:10.1002/14651858.CD012743.pub2
  • Battista SA, Lu Z, Hofmann S, Freddo T, Overby DR, Gong H. Reduction of the available area for aqueous humor outflow and increase in meshwork herniations into collector channels following acute IOP elevation in bovine eyes. Invest Ophthalmol Vis Sci. 2008;49(12):5346–5352. doi:10.1167/iovs.08-1707
  • Al Habash A, Khan O. Outcomes of combined iStent trabecular micro-bypass and cataract surgery for the treatment of open-angle glaucoma in a Saudi population. Clin Ophthalmol. 2020;14:1573–1580. doi:10.2147/OPTH.S249261
  • Gallardo MJ, Supnet RA, Giamporcaro JE, Hornbeak DM. Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population. Clin Ophthalmol. 2016;10:1931–1937. doi:10.2147/OPTH.S117403
  • Nitta K, Yamada Y, Morokado S, Sugiyama K. iStent trabecular micro-bypass stent implantation with cataract surgery in a Japanese glaucoma population. Clin Ophthalmol. 2020;14:3381–3391. doi:10.2147/OPTH.S274281
  • Mathew DJ, McKay BR, Basilious A, Belkin A, Trope GE, Buys YM. Adherence to World Glaucoma Association guidelines for surgical trials in the era of microinvasive glaucoma surgeries. Ophthalmol Glaucoma. 2019;2(2):78–85. doi:10.1016/j.ogla.2019.01.007
  • Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459–467. doi:10.1016/j.ophtha.2010.07.007
  • Kozera M, Konopinska J, Mariak Z, Rekas M. Effectiveness of iStent trabecular micro-bypass system combined with phacoemulsification vs. phacoemulsification alone in patients with glaucoma and cataract depending on the initial intraocular pressure. Ophthalmic Res. 2020. doi:10.1159/000511456
  • Heijl A, Leske MC, Hyman L, Yang Z, Bengtsson B. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial. Acta Ophthalmol. 2011;89(8):749–754. doi:10.1111/j.1755-3768.2009.01852.x
  • Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–1279. doi:10.1001/archopht.120.10.1268
  • Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology. 1999;106(3):556–563. doi:10.1016/S0161-6420(99)90116-1
  • Hoang TKH, Kim YK, Jeoung JW, Park KH. Relationship between age and surgical success after trabeculectomy with adjunctive mitomycin C. Eye (Lond). 2018;32(8):1321–1328. doi:10.1038/s41433-018-0071-x
  • Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(Suppl1):S57–S68. doi:10.1016/j.survophthal.2008.08.002
  • Patel I, de Klerk TA, Au L. Manchester iStent study: early results from a prospective UK case series. Clin Exp Ophthalmol. 2013;41(7):648–652. doi:10.1111/ceo.12098
  • Kim KE, Park KH. Update on the prevalence, etiology, diagnosis, and monitoring of normal-tension glaucoma. Asia Pac J Ophthalmol (Phila). 2016;5(1):23–31. doi:10.1097/APO.0000000000000177
  • Kim HJ, Lim SH. Clinical outcomes of trabecular microbypass stent (iStent) implantation in medically controlled open-angle glaucoma in the Korean population. Medicine (Baltimore). 2020;99(33):e21729. doi:10.1097/MD.0000000000021729